Keaveney Sam, Dragan Alina, Rata Mihaela, Blackledge Matthew, Scurr Erica, Winfield Jessica M, Shur Joshua, Koh Dow-Mu, Porta Nuria, Candito Antonio, King Alexander, Rennie Winston, Gaba Suchi, Suresh Priya, Malcolm Paul, Davis Amy, Nilak Anjumara, Shah Aarti, Gandhi Sanjay, Albrizio Mauro, Drury Arnold, Pratt Guy, Cook Gordon, Roberts Sadie, Jenner Matthew, Brown Sarah, Kaiser Martin, Messiou Christina
MRI Unit, The Royal Marsden NHS Foundation Trust, London, UK.
Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
Insights Imaging. 2023 Oct 15;14(1):170. doi: 10.1186/s13244-023-01498-3.
The Myeloma Response Assessment and Diagnosis System (MY-RADS) guidelines establish a standardised acquisition and analysis pipeline for whole-body MRI (WB-MRI) in patients with myeloma. This is the first study to assess image quality in a multi-centre prospective trial using MY-RADS.
The cohort consisted of 121 examinations acquired across ten sites with a range of prior WB-MRI experience, three scanner manufacturers and two field strengths. Image quality was evaluated qualitatively by a radiologist and quantitatively using a semi-automated pipeline to quantify common artefacts and image quality issues. The intra- and inter-rater repeatability of qualitative and quantitative scoring was also assessed.
Qualitative radiological scoring found that the image quality was generally good, with 94% of examinations rated as good or excellent and only one examination rated as non-diagnostic. There was a significant correlation between radiological and quantitative scoring for most measures, and intra- and inter-rater repeatability were generally good. When the quality of an overall examination was low, this was often due to low quality diffusion-weighted imaging (DWI), where signal to noise ratio (SNR), anterior thoracic signal loss and brain geometric distortion were found as significant predictors of examination quality.
It is possible to successfully deliver a multi-centre WB-MRI study using the MY-RADS protocol involving scanners with a range of manufacturers, models and field strengths. Quantitative measures of image quality were developed and shown to be significantly correlated with radiological assessment. The SNR of DW images was identified as a significant factor affecting overall examination quality.
ClinicalTrials.gov, NCT03188172 , Registered on 15 June 2017.
Good overall image quality, assessed both qualitatively and quantitatively, can be achieved in a multi-centre whole-body MRI study using the MY-RADS guidelines.
• A prospective multi-centre WB-MRI study using MY-RADS can be successfully delivered. • Quantitative image quality metrics were developed and correlated with radiological assessment. • SNR in DWI was identified as a significant predictor of quality, allowing for rapid quality adjustment.
骨髓瘤反应评估与诊断系统(MY-RADS)指南为骨髓瘤患者的全身MRI(WB-MRI)建立了标准化的采集和分析流程。这是第一项在多中心前瞻性试验中使用MY-RADS评估图像质量的研究。
该队列包括在10个地点进行的121次检查,这些地点具有不同的WB-MRI既往经验、3家扫描仪制造商和2种场强。由一名放射科医生对图像质量进行定性评估,并使用半自动流程进行定量评估,以量化常见伪影和图像质量问题。还评估了定性和定量评分的评分者内和评分者间重复性。
定性放射学评分发现图像质量总体良好,94%的检查被评为良好或优秀,只有一次检查被评为无法诊断。大多数测量指标的放射学评分与定量评分之间存在显著相关性,评分者内和评分者间重复性总体良好。当总体检查质量较低时,这通常是由于扩散加权成像(DWI)质量较低,其中信噪比(SNR)、前胸信号丢失和脑几何畸变被发现是检查质量的重要预测因素。
使用MY-RADS方案成功开展一项多中心WB-MRI研究是可行的,该研究涉及多种制造商、型号和场强的扫描仪。开发了图像质量的定量测量方法,并显示其与放射学评估显著相关。DW图像的SNR被确定为影响总体检查质量的一个重要因素。
ClinicalTrials.gov,NCT03188172,于2017年6月15日注册。
使用MY-RADS指南在多中心全身MRI研究中可以实现良好的总体图像质量,包括定性和定量评估。
• 使用MY-RADS的前瞻性多中心WB-MRI研究可以成功开展。
• 开发了定量图像质量指标并与放射学评估相关联。
• DWI中的SNR被确定为质量的重要预测因素,有助于快速进行质量调整。